On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Institut Curie

InstitutionResearch output, impact & collaborations

Institut Curie is a institution indexed in ScholarIQ from OpenAlex.

What is known about Institut Curie?

ScholarIQrecord summary

Institut Curie is a research organisation in Paris, FR. OpenAlex records 33,197 works and 4,850,179 citations for it. 5,630 researchers list it as their most recent affiliation.

How many works does Institut Curie have?

ScholarIQindexed works

Institut Curie has 33,197 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Institut Curie have?

ScholarIQcitation count

Institut Curie has 4,850,179 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Institut Curie?

ScholarIQresearcher count

Institut Curie has 5,630 researchers in the ScholarIQ index.

What is the average h-index at Institut Curie?

ScholarIQavg h-index

Institut Curie has an average h-index of 76.7 in OpenAlex.

What is the ROR of Institut Curie?

ScholarIQror

The ROR for Institut Curie is on the source record.

What is the OpenAlex record for Institut Curie?

ScholarIQopenalex

The OpenAlex for Institut Curie is on the source record.

Who are the most-cited researchers behind Institut Curie?

ScholarIQtop researchers by citations
1
Anne Vincent‐Salomon · Breast Cancer Treatment Studies
1,128 works62,738 citations
2
Sebastián Amigorena · Immunotherapy and Immune Responses
413 works60,022 citations
3
Odette Mariani · Cancer Genomics and Diagnostics
247 works45,344 citations
4
Xavier Sastre · Ocular Oncology and Treatments
202 works43,228 citations
5
Nicolas Girard · Lung Cancer Treatments and Mutations
904 works33,375 citations

What are the most-cited papers on Institut Curie?

ScholarIQmost cited works
Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
C. Focan, S. M. Steinberg, M Blichert-Toft, JF Forbes, Reagan Collins, Seri Anderson, R. Margreiter, C. S. Harwood, KW Andersen, Gemma Beighton, Riva Borovik, E. Aileen Clarke, T Yasutomi, W. Jonat, E. Mari, O Abe, R Peto, R Gray, JB Vermorken, Bernard Asselain, Mitchell A. Harris, I. Tengrup, P.C. Lara, Jean Laplanche, Summer Jackson, R. J. Sylvester, Hiroaki Ueo, P. Fumoleau, R. Sauer, WC Wood, Willi Sauerbrei, RS Gelman, Jennifer Redmond, A R Bianco, R. Arriagada, Megan Hauer, Marie Overgaard, Cunningham Mp, J. L. Hayward, M W Kissin, Owen Owen, W Jack, C Cooper, Pater Jl, Maho Ogawa, Jonathan Godwin, N. Scorpiglione, Palmer Mk, H Johansen, H. Hayat, A. Buzdar, H Muss, Hiroshi Sonoo, Diana Riley, G Brufman, M.J. Piccart-Gebhart, J Bryant, R Nissen, Hiroshi Koyama, Junji Uchino, Diana E. Parker, John L. Mace, Marion Durand, Giorgio Cocconi, Y Morishita, CF Oliveira, Comis Rl, A. Goldhirsch, M. Spielmann, JE Varhaug, Carsten Rose, J Bonte, Anthony Coates, CS McArdle, J. Price, John L. Powell, Lorella Vecchio, M. Schumacher, Mike Clarke, Antonio Nicolucci, Larry Norton, G Mathé, H Tooth, Rodrigo Huerta, Alexandra Velásquez, Norman Wolmark, NH Gordon, J. Houghton, M Baum, S. Gundersen, R H Creech, Gianni Bonadonna, D. Smith, R.J. Salmon, D.F. Hacking, R. Charles Coombes, Kathleen I. Pritchard, Y Lehingue, Jade Dignam, L. Mauriac
PubMed. 19982,156 Citations
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
Fátima Cardoso, Laura J. van’t Veer, Jan Bogaerts, Leen Slaets, Giuseppe Viale, Suzette Delaloge, Jean‐Yves Pierga, Étienne Brain, Sylvain Causeret, Mauro Delorenzi, Annuska M. Glas, Vassilis Golfinopoulos, Theodora Goulioti, Susan Knox, Erika Matos, Bart Meulemans, Peter A. Neijenhuis, Ulrike Nitz, Rodolfo Passalacqua, Peter M. Ravdin, Isabel T. Rubio, Mahasti Saghatchian, Tineke J. Smilde, Christos Sotiriou, Lisette Stork, Carolyn Straehle, Geraldine Thomas, Alastair M. Thompson, Jacobus M. van der Hoeven, Peter Vuylsteke, René Bernards, Konstantinos Tryfonidis, Emiel J. Rutgers, Martine Piccart
New England Journal of Medicine. 20162,075 CitationsOPEN ACCESS
New driver mutations in non-small-cell lung cancer
William Pao, Nicolas Girard
The Lancet Oncology. 20111,139 Citations
Amivantamab in EGFR Exon 20 Insertion–Mutated Non–Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study
Keunchil Park, Eric B. Haura, Natasha B. Leighl, Paul Mitchell, Catherine A. Shu, Nicolas Girard, Santiago Viteri, Ji‐Youn Han, Sang‐We Kim, Chee Khoon Lee, Joshua K. Sabari, Alexander I. Spira, Tsung‐Ying Yang, Dong‐Wan Kim, Ki Hyeong Lee, Rachel E. Sanborn, José Trigo, Kōichi Goto, Jong‐Seok Lee, James Chih‐Hsin Yang, Ramaswamy Govindan, Joshua Bauml, Pilar Garrido, Matthew Krebs, Karen L. Reckamp, John Xie, Joshua C. Curtin, Nahor Haddish‐Berhane, Amy Roshak, Dawn Millington, Patricia Lorenzini, Meena Thayu, Roland E. Knoblauch, Byoung Chul Cho
Journal of Clinical Oncology. 2021643 CitationsOPEN ACCESS
The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes
Alexander Marx, John Chan, Jean‐Michel Coindre, Frank Detterbeck, Nicolas Girard, Nancy L. Harris, Elaine S. Jaffe, Michael Kurrer, Edith M. Marom, André L. Moreira, Kiyoshi Mukai, Attilio Orazi, Philipp Ströbel
Journal of Thoracic Oncology. 2015613 Citations

How much of the research on Institut Curie is open access?

ScholarIQopen access share
58%OPEN ACCESS
Gold
0%
Green
8%
Hybrid
25%
Bronze
25%
Closed
42%

Related on ScholarIQ

470M+ articles · 14-day free trial